Literature DB >> 1337188

Remissions and relapses in idiopathic membranous nephropathy.

C Ponticelli1, P Passerini, P Altieri, F Locatelli, M Pappalettera.   

Abstract

To assess the significance of remissions and relapses in idiopathic nephrotic syndrome the outcome of 169 patients was reviewed of them III had either a complete or partial remission. The probability of obtaining a complete remission within 5 years was 44% for the whole group, being significantly higher (P = 0.015) for those patients who had been treated with steroids plus cytotoxic drugs. Of the 74 patients who had complete remission only two showed renal function deterioration over time. Relapse of non-nephrotic proteinuria occurred in 22 patients. Of these, 12 again entered complete remission spontaneously, which persisted in nine until the last observation. Relapse of nephrotic syndrome occurred in 42 of III patients. Six patients showed a moderate renal function deterioration. Of 27 untreated patients, 17 had again a partial or complete remission that persisted in 13 until the last observation. All the 15 patients submitted to treatment again entered remission, which persisted in nine of 11 patients given prednisolone and chlorambucil and only in one of four given steroids alone. In conclusion, (a) the development of complete remission is a good marker of an excellent renal outcome, (b) patients with relapse of non-nephrotic proteinuria usually carry a good prognosis, (c) about half of patients with relapse of nephrotic syndrome show a spontaneous remission, and (d) the chances of a stable remission may be increased by treatment with steroids and cytotoxic agents.

Entities:  

Mesh:

Year:  1992        PMID: 1337188

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  14 in total

1.  Relapse and its remission in Japanese patients with idiopathic membranous nephropathy.

Authors:  Shinji Kitajima; Kengo Furuichi; Norihiko Sakai; Akihiro Sagara; Yasuyuki Shinozaki; Tadashi Toyama; Yasunori Iwata; Miho Shimizu; Hitoshi Yokoyama; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2014-06-24       Impact factor: 2.801

2.  Combined Assessment of Phospholipase A2 Receptor Autoantibodies and Glomerular Deposits in Membranous Nephropathy.

Authors:  Hua-Zhang Qin; Ming-Chao Zhang; Wei-Bo Le; Qiang Ren; Da-Cheng Chen; Cai-Hong Zeng; Lei Liu; Ke Zuo; Feng Xu; Zhi-Hong Liu
Journal:  J Am Soc Nephrol       Date:  2016-03-17       Impact factor: 10.121

3.  Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy.

Authors:  Natalia Polanco; Elena Gutiérrez; Adelardo Covarsí; Francisco Ariza; Agustín Carreño; Ana Vigil; José Baltar; Gema Fernández-Fresnedo; Carmen Martín; Salvador Pons; Dolores Lorenzo; Carmen Bernis; Pilar Arrizabalaga; Gema Fernández-Juárez; Vicente Barrio; Milagros Sierra; Ines Castellanos; Mario Espinosa; Francisco Rivera; Aniana Oliet; Francisco Fernández-Vega; Manuel Praga
Journal:  J Am Soc Nephrol       Date:  2010-01-28       Impact factor: 10.121

4.  Complete and Partial Remission as Surrogate End Points in Membranous Nephropathy.

Authors:  Aliza Thompson; Daniel C Cattran; Melanie Blank; Patrick H Nachman
Journal:  J Am Soc Nephrol       Date:  2015-06-15       Impact factor: 10.121

5.  Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy.

Authors:  Jan A J G van den Brand; Julia M Hofstra; Jack F M Wetzels
Journal:  Clin J Am Soc Nephrol       Date:  2011-12       Impact factor: 8.237

6.  Late Relapses of Membranous Nephropathy: A Case Series.

Authors:  Yonatan Peleg; Andrew S Bomback; Pietro A Canetta; Jai Radhakrishnan; Gerald B Appel; Wooin Ahn
Journal:  Kidney360       Date:  2021-04-28

Review 7.  Primary membranous nephropathy: an endless story.

Authors:  Ponticelli Claudio
Journal:  J Nephrol       Date:  2022-10-17       Impact factor: 4.393

8.  Membranous Nephropathy: Quantifying Remission Duration on Outcome.

Authors:  Daniel C Cattran; Esther D Kim; Heather Reich; Michelle Hladunewich; S Joseph Kim
Journal:  J Am Soc Nephrol       Date:  2016-10-18       Impact factor: 10.121

Review 9.  Idiopathic membranous nephropathy: management strategies.

Authors:  Marco Quaglia; Piero Stratta
Journal:  Drugs       Date:  2009-07-09       Impact factor: 9.546

10.  Chapter 7: Idiopathic membranous nephropathy.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.